US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Savara Inc

2.21

+0.02000.91%

Post-market: 2.210.00000.00%16:20 EDT

Volume:768.18K

Turnover:1.68M

Market Cap:381.97M

PE:-4.47

High:2.23

Open:2.19

Low:2.15

Close:2.19

Loading ...

Overview Company News Filings

Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

THOMSON REUTERS

Savara Q4 Net Income USD -29.044 Million

THOMSON REUTERS

Savara Q4 Basic EPS USD -0.13 VS. Ibes Estimate USD -0.11

THOMSON REUTERS

Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Savara Gets Up to $200 Million Loan From Hercules Capital

BRIEF-Savara Enters Into Non-Dilutive Debt Financing For Up To $200M With Hercules Capital

Savara Files Biologics License Application to US FDA for Molbreevi to Treat Lung Disease

MT Newswires Live

Savara completes BLA submission to FDA for Molbreevi

BRIEF-Savara Completes Submission Of The Biologics License Application (BLA) To The U.S. Food And Drug Administration (FDA) For MOLBREEVI As A Treatment For Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Savara Completes Submission of the Biologics License Application (Bla) to the U.S. Food and Drug Administration (FDA) for Molbreevi* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (Apap)

THOMSON REUTERS

Savara Inc: Commercial Preparations Are on-Track to Support a Potential Launch in Early 2026

THOMSON REUTERS

Savara Inc - to Submit Molbreevi Maa in Europe by End of 2025

THOMSON REUTERS

Savara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Savara Inc expected to post a loss of 11 cents a share - Earnings Preview

Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society International Conference 2025

Savara Inc expected to post a loss of 11 cents a share - Earnings Preview

Savara Launches Test for Autoimmune Lung Disease in US; Shares Up Pre-Bell

MT Newswires Live

Savara Announces U.S. Launch of the aPAP ClearPath™ Dried Blood Spot Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Savara Inc expected to post a loss of 11 cents a share - Earnings Preview

Savara Announces Participation in the Leerink Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SVRA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","market":"US","secType":"STK","nameCN":"Savara Inc","latestPrice":2.21,"timestamp":1750968000000,"preClose":2.19,"halted":0,"volume":768180,"hourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.21,"latestTime":"16:20 EDT","volume":3078,"amount":6802.38,"timestamp":1750969200417},"delay":0,"floatShares":102000000,"shares":172836922,"eps":-0.494571,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"06-26 19:21:14 EDT","open":2.19,"high":2.23,"low":2.145,"amount":1681833.3222,"amplitude":0.038813,"askPrice":2.25,"askSize":1220,"bidPrice":2.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.494571,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750982400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.19,"preHourTrading":{"tag":"盘前","latestPrice":2.232,"preClose":2.19,"latestTime":"09:29 EDT","volume":1223,"amount":2649.6800099,"timestamp":1750944552843},"postHourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.21,"latestTime":"16:20 EDT","volume":3078,"amount":6802.38,"timestamp":1750969200417},"volumeRatio":0.753957,"impliedVol":0.4537,"impliedVolPercentile":0.352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","floatShares":102000000,"roa":"-38.97%","roe":"-75.77%","lyrEps":-0.483778,"volumeRatio":0.753957,"shares":172836922,"dividePrice":0,"high":2.23,"amplitude":0.038813,"preClose":2.19,"low":2.145,"week52Low":1.89,"pbRate":"2.58","week52High":5.11,"institutionHeld":0.7851,"latestPrice":2.21,"committee":-0.848485,"eps":-0.494571,"divideRate":0,"volume":768180,"delay":0,"ttmEps":-0.494571,"open":2.19,"prevYearClose":3.07,"prevWeekClose":2.06,"prevMonthClose":2.28,"prevQuarterClose":2.77,"fiveDayClose":2.07,"twentyDayClose":2.135,"sixtyDayClose":2.77},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVRA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522461375","title":"Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522461375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522461375?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:05","pubTimestamp":1743073500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA1STTQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2522375483","title":"Savara Q4 Net Income USD -29.044 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375483?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:05","pubTimestamp":1743073500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLXA15EB3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2522375457","title":"Savara Q4 Basic EPS USD -0.13 VS. Ibes Estimate USD -0.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375457?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:05","pubTimestamp":1743073500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLXA15EB3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2522752813","title":"Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522752813","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522752813?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:05","pubTimestamp":1743073500,"startTime":"0","endTime":"0","summary":"-- Completed Submission of the Biologics License Application  to the U.S. Food and Drug Administration  for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis  --. -- Priority Review Was Requested, Commercial Launch Preparations Underway --. \"Completing submission of the BLA is an important milestone in potentially addressing the significant unmet need of people living with aPAP, a rare and debilitating lung disease,\" said Matt Pauls, Chair and Chief Executive Officer, Savara. \"MOLBREEVI has the potential to be the first and only approved therapy for aPAP in the U.S. and Europe and could redefine the standard of care for the disease. If granted Priority Review, we could have a PDUFA date by the end of the year and are preparing for a commercial launch in early 2026. Lastly, with approximately $196 million in cash, we are in a strong financial position and believe our cash runway extends through 2Q 2027, excluding our recent debt financing which adds additional low-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-reports-fourth-quarter-end-110500201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4136","BK4588","LU1481599808.USD","LU1481600234.SGD","IP","LU2463526074.USD","LU1487256676.USD","PIM","BK4585","BK4139","SVRA"],"gpt_icon":0},{"id":"2522359103","title":"Savara Gets Up to $200 Million Loan From Hercules Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2522359103","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522359103?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:22","pubTimestamp":1743024147,"startTime":"0","endTime":"0","summary":"Savara  said Wednesday it entered into a loan and security agreement of up to $200 million with Hercules Capital .The debt financing strengthens Savara's balance sheet following its filing of a biologics license application with the US Food and Drug Administration for Molbreevi to treat autoimmune pulmonary alveolar proteinosis, a rare lung disease, the company said.If the FDA grants priority review, Molbreevi could be approved by the end of the year, Savara said, adding that it is also on track to file a marketing authorization application in Europe by year-end.Savara said $30 million was funded at the execution of the agreement and will be used to repay an existing $26.5 million debt facility. An additional $100 million will be available upon Molbreevi's FDA approval and other milestones.The final $70 million may be made available at Hercules Capital's discretion upon Savara's request, according to the company.Shares of Savara were up nearly 2% in after-hours trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-gets-200-million-loan-212227805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SVRA","BK4139","HTGC","BK4135"],"gpt_icon":0},{"id":"2522353018","title":"BRIEF-Savara Enters Into Non-Dilutive Debt Financing For Up To $200M With Hercules Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2522353018","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522353018?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:47","pubTimestamp":1743022024,"startTime":"0","endTime":"0","summary":"BRIEF-Savara Enters Into Non-Dilutive Debt Financing For Up To $200M With Hercules CapitalMarch 26 (Reuters) - Savara Inc SVRA.O:SAVARA ENTERS INTO NON-DILUTIVE DEBT FINANCING FOR UP TO $200M WITH HER","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q917T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4135","BK4139","HTGC"],"gpt_icon":0},{"id":"2522835377","title":"Savara Files Biologics License Application to US FDA for Molbreevi to Treat Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2522835377","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522835377?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:44","pubTimestamp":1743021886,"startTime":"0","endTime":"0","summary":"Savara  said late Wednesday it has completed submission of a biologics license application to the US Food and Drug Administration for Molbreevi to treat autoimmune pulmonary alveolar proteinosis, a rare lung disease.Savara requested priority review, which, if granted, will shorten the FDA's review to six months from the standard 10 months following the regulator's acceptance of the application, Chief Executive Matt Pauls said in a statement. The company remains on track with its commercial preparations to support a possible launch of the drug in early 2026, he added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2522585483","title":"Savara completes BLA submission to FDA for Molbreevi","url":"https://stock-news.laohu8.com/highlight/detail?id=2522585483","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522585483?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:11","pubTimestamp":1743019870,"startTime":"0","endTime":"0","summary":"Savara (SVRA) announced that it has completed submission of the BLA to the FDA for MOLBREEVI as a treatment for aPAP. “Submission of the BLA marks ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-completes-bla-submission-to-fda-for-molbreevi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-completes-bla-submission-to-fda-for-molbreevi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2522330496","title":"BRIEF-Savara Completes Submission Of The Biologics License Application (BLA) To The U.S. Food And Drug Administration (FDA) For MOLBREEVI As A Treatment For Autoimmune Pulmonary Alveolar Proteinosis (aPAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522330496","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522330496?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:07","pubTimestamp":1743019678,"startTime":"0","endTime":"0","summary":"BRIEF-Savara Completes Submission Of The Biologics License Application (BLA) To The U.S. Food And Drug Administration (FDA) For MOLBREEVI As A Treatment For Autoimmune Pulmonary Alveolar Proteinosis (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA3YKFVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2522998330","title":"Savara Completes Submission of the Biologics License Application (Bla) to the U.S. Food and Drug Administration (FDA) for Molbreevi* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (Apap)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522998330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522998330?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA3YKFVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2522333010","title":"Savara Inc: Commercial Preparations Are on-Track to Support a Potential Launch in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2522333010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522333010?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA3YKFVL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2522301243","title":"Savara Inc - to Submit Molbreevi Maa in Europe by End of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301243?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA3YKFVL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2522353711","title":"Savara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522353711","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522353711?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":"-- Priority Review Was Requested, Commercial Launch Preparations Underway --. LANGHORNE, Pa., March 26, 2025----Savara Inc.  , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has completed submission of the BLA to the FDA for MOLBREEVI as a treatment for aPAP.\"Submission of the BLA marks an important milestone for the Company and the aPAP community,\" said Matt Pauls, Chair and Chief Executive Officer, Savara. \"We believe this unprecedented body of data demonstrates MOLBREEVI improves pulmonary gas exchange and the clinical symptoms associated with this rare lung disease. As part of the submission, Priority Review was requested and, if granted, would shorten the FDA’s review to six months  following the Agency’s acceptance of the application. We look forward to continuing our dialogue with the FDA and extend our gratitude to the patients and physicians who participated in our clinical trials. Our commercial preparations are on-tra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-completes-submission-biologics-license-200500101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1481599808.USD","PIM","MAA","BK4215","SVRA","BK4588","IP","LU2463526074.USD","LU1481600234.SGD","BK4136","BK4139","LU1487256676.USD","BK4585"],"gpt_icon":0},{"id":"2521288795","title":"Savara Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288795","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288795?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:01","pubTimestamp":1742558483,"startTime":"0","endTime":"0","summary":"Savara Inc  expected to post a loss of11cents a share - Earnings Preview Savara Inc SVRA.OQ SVRA.O is expected to show no change in quarterly revenue when it reports  results on March 24 (estimated) f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q40X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA"],"gpt_icon":0},{"id":"2520520888","title":"Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society International Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520520888","media":"Business Wire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520520888?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:05","pubTimestamp":1742213100,"startTime":"0","endTime":"0","summary":"-- Company to Host Industry Theater on aPAP with Two World-Renowned Experts --. LANGHORNE, Pa., March 17, 2025----Savara Inc.  , a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of two abstracts for poster presentation at the American Thoracic Society  International Conference taking place May 16-21, 2025, in San Francisco, CA. The Company will also host an Industry Theater titled \"Advances in Autoimmune Pulmonary Alveolar Proteinosis \" at the meeting.The abstracts will be published in a supplement of the American Journal of Respiratory and Critical Care Medicine on May 1, 2025. For more details about the ATS International Conference please visit their website.aPAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Surfactant consists of proteins and lipids and is an important physiological substance that lines the alveoli to prevent them from collapsing. In a healthy lu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-present-data-phase-3-120500851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4117","ATS","AFG","BK4161","SVRA","BK4107","BK4139"],"gpt_icon":0},{"id":"2518244943","title":"Savara Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244943?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:05","pubTimestamp":1741604737,"startTime":"0","endTime":"0","summary":"Savara Inc  expected to post a loss of11cents a share - Earnings Preview Savara Inc SVRA.OQ SVRA.O is expected to show no change in quarterly revenue when it reports  results on March 12 (estimated) f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT0M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA"],"gpt_icon":0},{"id":"2517150949","title":"Savara Launches Test for Autoimmune Lung Disease in US; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150949","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150949?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:54","pubTimestamp":1741269245,"startTime":"0","endTime":"0","summary":"Savara  said Thursday it has launched its aPAP ClearPath dried blood spot test in the US.The test is designed to help obtain a diagnosis of aPAP, a rare autoimmune lung disease, through a finger-prick blood sample, the company said.The DBS test has achieved 100% sensitivity and specificity in  a group of individuals with aPAP autoantibody status, Savara said.Shares were almost 2% higher in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2517157843","title":"Savara Announces U.S. Launch of the aPAP ClearPath™ Dried Blood Spot Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157843","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157843?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:05","pubTimestamp":1741266300,"startTime":"0","endTime":"0","summary":"-- The Simple, No-cost Test Can Detect Granulocyte-Macrophage Colony Stimulating Factor  Autoantibodies in the Blood with Only a Finger Prick --. LANGHORNE, Pa., March 06, 2025----Savara Inc.  , a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot  Test in the U.S., an evolution of the first serum-based assay the Company launched. The DBS test helps obtain a diagnosis of aPAP, a rare autoimmune lung disease caused by antibodies targeting GM-CSF, with only a finger-prick blood sample.Autoimmune PAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli  of the lungs. Surfactant consists of proteins and lipids and is an important physiological substance that lines the alveoli to prevent them from collapsing. In a healthy lung, excess surfactant is cleared and digested by immune cells called alveolar macrophages. Alveolar macrophages need to be stimulated by granuloc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-announces-u-launch-apap-130500207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DBS","LU0648001328.SGD","LU0072461881.USD","BK4516","BK4099","LU0130103400.USD","LU1201861249.SGD","BK4555","LU0130518102.USD","LU0130517989.USD","CLIA","LU0320765489.SGD","LU1201861165.SGD","LU0208291251.USD","BK4561","LU0211331839.USD","LU0070302665.USD","LU0477156797.USD","BK4559","LU0980610538.SGD","BK4139","BK4588","LU0130102774.USD","LU0345770993.USD","BK4585","LU0006061336.USD","BK4566","LU0648000940.SGD","LU0162691827.USD","LU0477156953.USD","SVRA","BK4596","LU0345770308.USD","BK4574","GM"],"gpt_icon":0},{"id":"2517972669","title":"Savara Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517972669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517972669?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:02","pubTimestamp":1741172564,"startTime":"0","endTime":"0","summary":"Savara Inc  expected to post a loss of11cents a share - Earnings Preview Savara Inc SVRA.OQ SVRA.O is expected to show no change in quarterly revenue when it reports  results on March 7 (estimated) fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL5N3PO0VA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA"],"gpt_icon":0},{"id":"2516669026","title":"Savara Announces Participation in the Leerink Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516669026","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516669026?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:15","pubTimestamp":1741036500,"startTime":"0","endTime":"0","summary":"LANGHORNE, Pa., March 03, 2025----Savara Inc.  , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the Leerink Global Healthcare Conference and participate in a fireside chat on Tuesday, March 11th, 10:40am ET/7:40am PT.*MOLBREEVI is the FDA and EMA conditionally accepted trade name for molgramostim inhalation solution. It is not approved in any indication.Media and Investor Relations Contact Savara Inc.Temre Johnson, Executive Director, Corporate Affairsir@savarapharma.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/savara-announces-participation-leerink-global-211500578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HCSG","BK4139","BK4137","SVRA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"SVRA","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-03-27","symbol":"SVRA","fiscalQuarterEnding":"2024/12","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-11-12","symbol":"SVRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-08-12","symbol":"SVRA","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2024-05-09","symbol":"SVRA","fiscalQuarterEnding":"2024/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1748577600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVRA","date":"2025-06-25","current":-4.701523,"percent":0.50528,"low":-15.250395,"twenty":-9.408226,"median":-4.745129,"eighty":-2.981712,"high":-0.800989,"avg":-5.896926,"sd":3.620499,"marketCap":480373412},"quantilePoints":[{"date":"2020-06-26","current":-1.761302,"twenty":-14.60086,"median":-6.185661,"eighty":-1.74929,"marketCap":143514423},{"date":"2020-07-02","current":-1.364209,"twenty":-14.60086,"median":-6.162956,"eighty":-1.728915,"marketCap":111158444},{"date":"2020-07-10","current":-1.351399,"twenty":-14.589672,"median":-6.022741,"eighty":-1.707213,"marketCap":110114702},{"date":"2020-07-17","current":-1.33859,"twenty":-14.544918,"median":-5.998757,"eighty":-1.673147,"marketCap":109070961},{"date":"2020-07-24","current":-1.178471,"twenty":-14.477788,"median":-5.887863,"eighty":-1.665935,"marketCap":96024195},{"date":"2020-07-31","current":-1.274542,"twenty":-14.326011,"median":-5.751522,"eighty":-1.658826,"marketCap":103852255},{"date":"2020-08-07","current":-1.664696,"twenty":-14.2539,"median":-5.737879,"eighty":-1.658362,"marketCap":114752473},{"date":"2020-08-14","current":-1.468387,"twenty":-14.209266,"median":-5.662673,"eighty":-1.652422,"marketCap":101220341},{"date":"2020-08-21","current":-1.256374,"twenty":-14.209266,"median":-5.623907,"eighty":-1.6443,"marketCap":86605640},{"date":"2020-08-28","current":-1.115032,"twenty":-14.186889,"median":-5.579747,"eighty":-1.629876,"marketCap":76862505},{"date":"2020-09-04","current":-0.981542,"twenty":-14.130947,"median":-5.563322,"eighty":-1.60824,"marketCap":67660656},{"date":"2020-09-11","current":-0.934428,"twenty":-14.014588,"median":-5.538284,"eighty":-1.601738,"marketCap":64412944},{"date":"2020-09-18","current":-0.997247,"twenty":-13.892547,"median":-5.479516,"eighty":-1.593422,"marketCap":68743226},{"date":"2020-09-25","current":-0.934428,"twenty":-13.863803,"median":-5.448438,"eighty":-1.586605,"marketCap":64412944},{"date":"2020-10-02","current":-0.855905,"twenty":-13.701312,"median":-5.412321,"eighty":-1.574284,"marketCap":59000092},{"date":"2020-10-09","current":-0.997247,"twenty":-13.539211,"median":-5.397049,"eighty":-1.566495,"marketCap":68743226},{"date":"2020-10-16","current":-0.926576,"twenty":-13.470296,"median":-5.302364,"eighty":-1.557757,"marketCap":63871659},{"date":"2020-10-23","current":-0.926576,"twenty":-13.422222,"median":-5.289826,"eighty":-1.556351,"marketCap":63871659},{"date":"2020-10-30","current":-0.816643,"twenty":-13.374149,"median":-5.259889,"eighty":-1.546595,"marketCap":56293666},{"date":"2020-11-06","current":-0.841039,"twenty":-13.360065,"median":-5.230206,"eighty":-1.527306,"marketCap":56848338},{"date":"2020-11-13","current":-0.833029,"twenty":-13.349997,"median":-5.186298,"eighty":-1.505113,"marketCap":56306926},{"date":"2020-11-20","current":-0.945167,"twenty":-13.294055,"median":-5.134076,"eighty":-1.484092,"marketCap":63886704},{"date":"2020-11-27","current":-1.065316,"twenty":-13.273916,"median":-5.085627,"eighty":-1.476376,"marketCap":72007895},{"date":"2020-12-04","current":-1.153425,"twenty":-13.269441,"median":-5.054956,"eighty":-1.46638,"marketCap":77963436},{"date":"2020-12-11","current":-0.969197,"twenty":-13.268808,"median":-4.928793,"eighty":-1.451619,"marketCap":65510942},{"date":"2020-12-18","current":-1.089346,"twenty":-13.262306,"median":-4.819775,"eighty":-1.416821,"marketCap":73632134},{"date":"2020-12-24","current":-1.049296,"twenty":-13.240351,"median":-4.813667,"eighty":-1.39703,"marketCap":70925070},{"date":"2020-12-31","current":-0.921138,"twenty":-13.204548,"median":-4.777014,"eighty":-1.378717,"marketCap":62262466},{"date":"2021-01-08","current":-1.049296,"twenty":-13.153081,"median":-4.745618,"eighty":-1.367168,"marketCap":70925070},{"date":"2021-01-15","current":-1.161435,"twenty":-13.088188,"median":-4.728145,"eighty":-1.353723,"marketCap":78504848},{"date":"2021-01-22","current":-1.433771,"twenty":-13.079238,"median":-4.70371,"eighty":-1.352703,"marketCap":96912882},{"date":"2021-01-29","current":-1.225514,"twenty":-13.07609,"median":-4.664003,"eighty":-1.344994,"marketCap":82836150},{"date":"2021-02-05","current":-1.553919,"twenty":-12.978542,"median":-4.65484,"eighty":-1.33859,"marketCap":105034073},{"date":"2021-02-12","current":-1.401731,"twenty":-12.967354,"median":-4.638941,"eighty":-1.33859,"marketCap":94747231},{"date":"2021-02-19","current":-1.377702,"twenty":-12.949452,"median":-4.636514,"eighty":-1.343713,"marketCap":93122993},{"date":"2021-02-26","current":-1.361682,"twenty":-12.891273,"median":-4.62988,"eighty":-1.350118,"marketCap":92040167},{"date":"2021-03-05","current":-1.305613,"twenty":-12.863376,"median":-4.621344,"eighty":-1.350118,"marketCap":88250278},{"date":"2021-03-12","current":-3.165054,"twenty":-12.829476,"median":-4.612647,"eighty":-1.350118,"marketCap":157034153},{"date":"2021-03-19","current":-4.660928,"twenty":-12.812954,"median":-4.617041,"eighty":-1.352442,"marketCap":231251921},{"date":"2021-03-26","current":-3.715232,"twenty":-12.757012,"median":-4.60597,"eighty":-1.356784,"marketCap":184331241},{"date":"2021-04-01","current":-5.066226,"twenty":-12.741178,"median":-4.60597,"eighty":-1.358646,"marketCap":251360784},{"date":"2021-04-09","current":-4.390729,"twenty":-12.710729,"median":-4.602916,"eighty":-1.360692,"marketCap":217846012},{"date":"2021-04-16","current":-4.0061,"twenty":-12.689186,"median":-4.593753,"eighty":-1.363198,"marketCap":198762644},{"date":"2021-04-23","current":-4.532616,"twenty":-12.680931,"median":-4.581348,"eighty":-1.365468,"marketCap":224885734},{"date":"2021-04-30","current":-4.34948,"twenty":-12.67106,"median":-4.569318,"eighty":-1.368891,"marketCap":215799442},{"date":"2021-05-07","current":-3.731396,"twenty":-12.659433,"median":-4.547937,"eighty":-1.372741,"marketCap":185133206},{"date":"2021-05-14","current":-3.991883,"twenty":-12.647687,"median":-4.538775,"eighty":-1.376285,"marketCap":177283502},{"date":"2021-05-21","current":-4.375718,"twenty":-12.629678,"median":-4.535319,"eighty":-1.377702,"marketCap":194329993},{"date":"2021-05-28","current":-4.606018,"twenty":-12.607087,"median":-4.537972,"eighty":-1.377702,"marketCap":204557887},{"date":"2021-06-04","current":-4.631607,"twenty":-12.584711,"median":-4.538775,"eighty":-1.377702,"marketCap":205694320},{"date":"2021-06-11","current":-4.682785,"twenty":-12.532821,"median":-4.547937,"eighty":-1.378108,"marketCap":207967185},{"date":"2021-06-18","current":-4.529252,"twenty":-12.472192,"median":-4.554841,"eighty":-1.378717,"marketCap":201148589},{"date":"2021-06-25","current":-4.529252,"twenty":-12.452064,"median":-4.547937,"eighty":-1.378717,"marketCap":201148589},{"date":"2021-07-02","current":-4.06865,"twenty":-12.447278,"median":-4.538775,"eighty":-1.381515,"marketCap":180692800},{"date":"2021-07-09","current":-3.896613,"twenty":-12.425835,"median":-4.537972,"eighty":-1.385712,"marketCap":173052477},{"date":"2021-07-16","current":-3.486443,"twenty":-12.36154,"median":-4.530934,"eighty":-1.385712,"marketCap":154836427},{"date":"2021-07-23","current":-3.409536,"twenty":-12.350175,"median":-4.526557,"eighty":-1.387816,"marketCap":151420917},{"date":"2021-07-30","current":-3.281358,"twenty":-12.321729,"median":-4.520448,"eighty":-1.396232,"marketCap":145728401},{"date":"2021-08-06","current":-3.230087,"twenty":-12.231582,"median":-4.514995,"eighty":-1.396631,"marketCap":143451395},{"date":"2021-08-13","current":-2.947628,"twenty":-11.975524,"median":-4.505177,"eighty":-1.398928,"marketCap":135478860},{"date":"2021-08-20","current":-3.071478,"twenty":-11.799285,"median":-4.496014,"eighty":-1.403193,"marketCap":141171249},{"date":"2021-08-27","current":-3.542107,"twenty":-11.689386,"median":-4.462032,"eighty":-1.409182,"marketCap":162802328},{"date":"2021-09-03","current":-3.839347,"twenty":-11.217586,"median":-4.410492,"eighty":-1.410882,"marketCap":176464062},{"date":"2021-09-10","current":-3.591647,"twenty":-10.802353,"median":-4.401307,"eighty":-1.415446,"marketCap":165079283},{"date":"2021-09-17","current":-3.443027,"twenty":-10.699669,"median":-4.3851,"eighty":-1.417737,"marketCap":158248416},{"date":"2021-09-24","current":-3.220097,"twenty":-10.679132,"median":-4.375718,"eighty":-1.417751,"marketCap":148002116},{"date":"2021-10-01","current":-3.319177,"twenty":-10.442959,"median":-4.367971,"eighty":-1.417751,"marketCap":152556027},{"date":"2021-10-08","current":-3.294407,"twenty":-10.432691,"median":-4.350129,"eighty":-1.430744,"marketCap":151417550},{"date":"2021-10-15","current":-3.195327,"twenty":-10.391617,"median":-4.34948,"eighty":-1.433771,"marketCap":146863638},{"date":"2021-10-22","current":-2.997168,"twenty":-10.330007,"median":-4.326588,"eighty":-1.433771,"marketCap":137755816},{"date":"2021-10-29","current":-2.873318,"twenty":-10.330007,"median":-4.278431,"eighty":-1.441065,"marketCap":132063427},{"date":"2021-11-05","current":-2.972398,"twenty":-10.206786,"median":-4.233525,"eighty":-1.441781,"marketCap":136617338},{"date":"2021-11-12","current":-2.831373,"twenty":-10.199059,"median":-4.210516,"eighty":-1.441781,"marketCap":128671754},{"date":"2021-11-19","current":-2.706091,"twenty":-10.024453,"median":-4.202795,"eighty":-1.441781,"marketCap":122978313},{"date":"2021-11-26","current":-2.881486,"twenty":-9.917635,"median":-4.190578,"eighty":-1.443357,"marketCap":130949130},{"date":"2021-12-03","current":-2.655978,"twenty":-9.874496,"median":-4.159412,"eighty":-1.454242,"marketCap":120700937},{"date":"2021-12-10","current":-2.605866,"twenty":-9.788221,"median":-4.129491,"eighty":-1.457614,"marketCap":118423561},{"date":"2021-12-17","current":-2.956655,"twenty":-9.743029,"median":-4.105056,"eighty":-1.462169,"marketCap":134365194},{"date":"2021-12-23","current":-3.232276,"twenty":-9.69989,"median":-4.096593,"eighty":-1.463261,"marketCap":146890763},{"date":"2021-12-31","current":-3.106994,"twenty":-9.673793,"median":-4.05298,"eighty":-1.463326,"marketCap":141197323},{"date":"2022-01-07","current":-3.282388,"twenty":-9.655788,"median":-4.006708,"eighty":-1.46638,"marketCap":149168139},{"date":"2022-01-14","current":-3.257332,"twenty":-9.570476,"median":-3.985431,"eighty":-1.469278,"marketCap":148029451},{"date":"2022-01-21","current":-2.881486,"twenty":-9.517068,"median":-3.938427,"eighty":-1.471159,"marketCap":130949130},{"date":"2022-01-28","current":-2.85643,"twenty":-9.509957,"median":-3.909431,"eighty":-1.473381,"marketCap":129810442},{"date":"2022-02-04","current":-3.081937,"twenty":-9.504428,"median":-3.896613,"eighty":-1.474842,"marketCap":140058635},{"date":"2022-02-11","current":-3.006768,"twenty":-9.486889,"median":-3.881309,"eighty":-1.476376,"marketCap":136642570},{"date":"2022-02-18","current":-2.78126,"twenty":-9.460663,"median":-3.84849,"eighty":-1.477623,"marketCap":126394377},{"date":"2022-02-25","current":-2.756204,"twenty":-9.445342,"median":-3.839347,"eighty":-1.479961,"marketCap":125255689},{"date":"2022-03-04","current":-2.756204,"twenty":-9.43811,"median":-3.808811,"eighty":-1.482282,"marketCap":125255689},{"date":"2022-03-11","current":-2.706091,"twenty":-9.431308,"median":-3.768435,"eighty":-1.484092,"marketCap":122978313},{"date":"2022-03-18","current":-3.257332,"twenty":-9.410249,"median":-3.731396,"eighty":-1.486429,"marketCap":148029451},{"date":"2022-03-25","current":-3.081937,"twenty":-9.366646,"median":-3.708504,"eighty":-1.4958,"marketCap":140058635},{"date":"2022-04-01","current":-3.499619,"twenty":-9.311844,"median":-3.597148,"eighty":-1.497733,"marketCap":150532615},{"date":"2022-04-08","current":-3.499619,"twenty":-9.262945,"median":-3.56335,"eighty":-1.505113,"marketCap":150532615},{"date":"2022-04-14","current":-3.340545,"twenty":-9.257117,"median":-3.542107,"eighty":-1.505113,"marketCap":143690223},{"date":"2022-04-22","current":-3.261009,"twenty":-9.233589,"median":-3.521352,"eighty":-1.505113,"marketCap":140269027},{"date":"2022-04-29","current":-3.128447,"twenty":-9.200262,"median":-3.499619,"eighty":-1.510539,"marketCap":134567034},{"date":"2022-05-06","current":-3.048911,"twenty":-9.104739,"median":-3.444811,"eighty":-1.510539,"marketCap":131145839},{"date":"2022-05-13","current":-3.468662,"twenty":-9.032946,"median":-3.420082,"eighty":-1.510539,"marketCap":142551588},{"date":"2022-05-20","current":-3.801653,"twenty":-8.916829,"median":-3.420082,"eighty":-1.510539,"marketCap":156236541},{"date":"2022-05-27","current":-3.662907,"twenty":-8.862364,"median":-3.420082,"eighty":-1.510539,"marketCap":150534477},{"date":"2022-06-03","current":-3.746155,"twenty":-8.73459,"median":-3.420082,"eighty":-1.510539,"marketCap":153955715},{"date":"2022-06-10","current":-3.91265,"twenty":-8.186259,"median":-3.420082,"eighty":-1.510539,"marketCap":160798192},{"date":"2022-06-17","current":-3.607408,"twenty":-7.972847,"median":-3.420082,"eighty":-1.510539,"marketCap":148253652},{"date":"2022-06-24","current":-4.356639,"twenty":-7.810479,"median":-3.420082,"eighty":-1.509183,"marketCap":179044795},{"date":"2022-07-01","current":-4.273391,"twenty":-7.710825,"median":-3.420082,"eighty":-1.509183,"marketCap":175623557},{"date":"2022-07-08","current":-5.161369,"twenty":-7.620641,"median":-3.420082,"eighty":-1.509183,"marketCap":212116764},{"date":"2022-07-15","current":-4.939374,"twenty":-7.600302,"median":-3.420082,"eighty":-1.509183,"marketCap":202993462},{"date":"2022-07-22","current":-4.967124,"twenty":-7.582154,"median":-3.420082,"eighty":-1.509183,"marketCap":204133875},{"date":"2022-07-29","current":-4.495386,"twenty":-7.569092,"median":-3.420082,"eighty":-1.509183,"marketCap":184746859},{"date":"2022-08-05","current":-4.828377,"twenty":-7.552842,"median":-3.420082,"eighty":-1.509183,"marketCap":198431811},{"date":"2022-08-12","current":-4.959637,"twenty":-7.50861,"median":-3.420082,"eighty":-1.509183,"marketCap":195012917},{"date":"2022-08-19","current":-4.785614,"twenty":-7.441671,"median":-3.420082,"eighty":-1.509183,"marketCap":188170359},{"date":"2022-08-26","current":-4.147533,"twenty":-7.384548,"median":-3.420082,"eighty":-1.509183,"marketCap":163080978},{"date":"2022-09-02","current":-4.20554,"twenty":-7.353882,"median":-3.420082,"eighty":-1.509183,"marketCap":165361830},{"date":"2022-09-09","current":-4.292551,"twenty":-7.292493,"median":-3.420082,"eighty":-1.509183,"marketCap":168783110},{"date":"2022-09-16","current":-4.350559,"twenty":-7.23411,"median":-3.420082,"eighty":-1.509183,"marketCap":171063963},{"date":"2022-09-23","current":-4.118529,"twenty":-7.185667,"median":-3.420082,"eighty":-1.509183,"marketCap":161940551},{"date":"2022-09-30","current":-4.495577,"twenty":-7.131131,"median":-3.420082,"eighty":-1.509183,"marketCap":176766095},{"date":"2022-10-07","current":-3.799488,"twenty":-6.953497,"median":-3.420082,"eighty":-1.509183,"marketCap":149395861},{"date":"2022-10-14","current":-3.538454,"twenty":-6.76637,"median":-3.420082,"eighty":-1.509183,"marketCap":139132023},{"date":"2022-10-21","current":-3.567458,"twenty":-6.674372,"median":-3.418257,"eighty":-1.509183,"marketCap":140272449},{"date":"2022-10-28","current":-3.596462,"twenty":-6.528013,"median":-3.409536,"eighty":-1.509183,"marketCap":141412876},{"date":"2022-11-04","current":-3.306424,"twenty":-6.435942,"median":-3.39357,"eighty":-1.509183,"marketCap":130008611},{"date":"2022-11-11","current":-3.407341,"twenty":-6.335605,"median":-3.393436,"eighty":-1.509183,"marketCap":133431481},{"date":"2022-11-18","current":-3.989793,"twenty":-6.251734,"median":-3.393436,"eighty":-1.509183,"marketCap":156240281},{"date":"2022-11-25","current":-4.193651,"twenty":-6.184618,"median":-3.393436,"eighty":-1.509183,"marketCap":164223361},{"date":"2022-12-02","current":-4.717857,"twenty":-6.013388,"median":-3.393436,"eighty":-1.509183,"marketCap":184751281},{"date":"2022-12-09","current":-4.601367,"twenty":-5.8031,"median":-3.393436,"eighty":-1.509183,"marketCap":180189521},{"date":"2022-12-16","current":-4.426631,"twenty":-5.727576,"median":-3.393436,"eighty":-1.509183,"marketCap":173346881},{"date":"2022-12-23","current":-4.368386,"twenty":-5.610336,"median":-3.393436,"eighty":-1.509183,"marketCap":171066001},{"date":"2022-12-30","current":-4.513999,"twenty":-5.561222,"median":-3.393436,"eighty":-1.509183,"marketCap":176768201},{"date":"2023-01-06","current":-5.067328,"twenty":-5.484318,"median":-3.393436,"eighty":-1.509183,"marketCap":198436561},{"date":"2023-01-13","current":-5.329431,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":208700521},{"date":"2023-01-20","current":-6.086618,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":238351962},{"date":"2023-01-27","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-03","current":-6.872928,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":269143842},{"date":"2023-02-10","current":-7.105908,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":278267362},{"date":"2023-02-17","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-24","current":-7.368011,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":288531322},{"date":"2023-03-03","current":-6.90205,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":270284282},{"date":"2023-03-10","current":-6.144863,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":240632842},{"date":"2023-03-17","current":-5.911883,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":231509322},{"date":"2023-03-24","current":-5.824515,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":228088002},{"date":"2023-03-31","current":-5.830308,"twenty":-5.430741,"median":-3.393436,"eighty":-1.510539,"marketCap":222426235},{"date":"2023-04-06","current":-5.052933,"twenty":-5.408841,"median":-3.393436,"eighty":-1.510539,"marketCap":192769403},{"date":"2023-04-14","current":-5.232327,"twenty":-5.29765,"median":-3.393436,"eighty":-1.509183,"marketCap":199613288},{"date":"2023-04-21","current":-5.501418,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":209879114},{"date":"2023-04-28","current":-5.561216,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":212160408},{"date":"2023-05-05","current":-5.680813,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":216722998},{"date":"2023-05-12","current":-5.800409,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":221285587},{"date":"2023-05-19","current":-7.226612,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":292005724},{"date":"2023-05-26","current":-7.283156,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":294290486},{"date":"2023-06-02","current":-8.271181,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":334213614},{"date":"2023-06-09","current":-8.32764,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":336494936},{"date":"2023-06-16","current":-8.976913,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":362730134},{"date":"2023-06-23","current":-8.242952,"twenty":-5.335182,"median":-3.393436,"eighty":-1.507826,"marketCap":333072953},{"date":"2023-06-30","current":-7.621907,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":307978416},{"date":"2023-07-07","current":-8.497015,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":343338900},{"date":"2023-07-14","current":-9.132174,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":369003768},{"date":"2023-07-21","current":-11.632389,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":470029958},{"date":"2023-07-28","current":-10.963861,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":443016742},{"date":"2023-08-04","current":-11.933227,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":482185905},{"date":"2023-08-11","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-08-18","current":-10.893423,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":464996637},{"date":"2023-08-25","current":-11.590095,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":494734794},{"date":"2023-09-01","current":-11.463427,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":489327856},{"date":"2023-09-08","current":-12.033432,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":513659075},{"date":"2023-09-15","current":-11.653429,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":497438262},{"date":"2023-09-22","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-09-29","current":-11.970098,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":510955606},{"date":"2023-10-06","current":-11.938431,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":509603872},{"date":"2023-10-13","current":-10.355085,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":442017152},{"date":"2023-10-20","current":-10.101749,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":431203276},{"date":"2023-10-27","current":-11.115091,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":474458777},{"date":"2023-11-03","current":-11.400093,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":486624387},{"date":"2023-11-10","current":-9.426398,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":460941433},{"date":"2023-11-17","current":-9.977799,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":487904391},{"date":"2023-11-24","current":-10.517513,"twenty":-5.313191,"median":-3.381076,"eighty":-1.505113,"marketCap":514295891},{"date":"2023-12-01","current":-10.655902,"twenty":-5.338428,"median":-3.381076,"eighty":-1.505113,"marketCap":521062942},{"date":"2023-12-08","current":-11.126422,"twenty":-5.415071,"median":-3.393436,"eighty":-1.505113,"marketCap":544070916},{"date":"2023-12-15","current":-12.316562,"twenty":-5.475519,"median":-3.393436,"eighty":-1.505113,"marketCap":602267556},{"date":"2023-12-22","current":-12.980826,"twenty":-5.561216,"median":-3.393436,"eighty":-1.505113,"marketCap":634749402},{"date":"2023-12-29","current":-13.340635,"twenty":-5.590213,"median":-3.381076,"eighty":-1.505113,"marketCap":652343735},{"date":"2024-01-05","current":-12.039785,"twenty":-5.620881,"median":-3.368717,"eighty":-1.505113,"marketCap":588733454},{"date":"2024-01-12","current":-11.596942,"twenty":-5.710712,"median":-3.368717,"eighty":-1.505113,"marketCap":567078890},{"date":"2024-01-19","current":-11.818364,"twenty":-5.829149,"median":-3.367888,"eighty":-1.505113,"marketCap":577906172},{"date":"2024-01-26","current":-13.783478,"twenty":-5.911883,"median":-3.368717,"eighty":-1.505113,"marketCap":673998299},{"date":"2024-02-02","current":-14.0049,"twenty":-6.006255,"median":-3.368717,"eighty":-1.505113,"marketCap":684825581},{"date":"2024-02-09","current":-13.202247,"twenty":-6.098621,"median":-3.368717,"eighty":-1.505113,"marketCap":645576684},{"date":"2024-02-16","current":-13.755801,"twenty":-6.227598,"median":-3.368717,"eighty":-1.505113,"marketCap":672644889},{"date":"2024-02-23","current":-13.589734,"twenty":-6.366195,"median":-3.368717,"eighty":-1.505113,"marketCap":664524427},{"date":"2024-03-01","current":-13.977222,"twenty":-6.479218,"median":-3.381076,"eighty":-1.505113,"marketCap":683472171},{"date":"2024-03-08","current":-13.831517,"twenty":-6.90205,"median":-3.381076,"eighty":-1.505113,"marketCap":756556324},{"date":"2024-03-15","current":-11.769541,"twenty":-7.041838,"median":-3.381076,"eighty":-1.505113,"marketCap":643770337},{"date":"2024-03-22","current":-12.350441,"twenty":-7.184539,"median":-3.381076,"eighty":-1.505113,"marketCap":675544409},{"date":"2024-03-28","current":-12.249415,"twenty":-7.248225,"median":-3.381076,"eighty":-1.505113,"marketCap":670018483},{"date":"2024-04-05","current":-11.643258,"twenty":-7.32724,"median":-3.368717,"eighty":-1.505113,"marketCap":636862930},{"date":"2024-04-12","current":-13.486984,"twenty":-7.368011,"median":-3.368717,"eighty":-1.505113,"marketCap":737711072},{"date":"2024-04-19","current":-12.100371,"twenty":-7.497698,"median":-3.368717,"eighty":-1.505113,"marketCap":661866110},{"date":"2024-04-26","current":-11.241472,"twenty":-7.68836,"median":-3.381076,"eighty":-1.505113,"marketCap":614886052},{"date":"2024-05-03","current":-11.822492,"twenty":-7.80485,"median":-3.381076,"eighty":-1.505113,"marketCap":646666679},{"date":"2024-05-10","current":-10.864479,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":700617677},{"date":"2024-05-17","current":-10.114466,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":652251565},{"date":"2024-05-24","current":-8.935874,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":576247675},{"date":"2024-05-31","current":-8.8073,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":567956342},{"date":"2024-06-07","current":-8.614439,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":555519341},{"date":"2024-06-14","current":-8.700155,"twenty":-8.073576,"median":-3.393436,"eighty":-1.505113,"marketCap":561046897},{"date":"2024-06-21","current":-7.971571,"twenty":-8.211511,"median":-3.393487,"eighty":-1.505113,"marketCap":514062674},{"date":"2024-06-28","current":-8.164431,"twenty":-8.254244,"median":-3.407341,"eighty":-1.505113,"marketCap":526499674},{"date":"2024-07-05","current":-11.041081,"twenty":-8.350223,"median":-3.420082,"eighty":-1.505113,"marketCap":712006195},{"date":"2024-07-12","current":-12.928009,"twenty":-8.542182,"median":-3.422439,"eighty":-1.505113,"marketCap":833688547},{"date":"2024-07-15","current":-12.469027,"twenty":-8.611735,"median":-3.435172,"eighty":-1.505113,"marketCap":804090137},{"date":"2024-08-02","current":-11.576561,"twenty":-8.657297,"median":-3.483445,"eighty":-1.495778,"marketCap":746537673},{"date":"2024-08-09","current":-10.327108,"twenty":-8.743013,"median":-3.517337,"eighty":-1.495778,"marketCap":665964224},{"date":"2024-08-16","current":-9.860251,"twenty":-8.835767,"median":-3.540281,"eighty":-1.495778,"marketCap":742348719},{"date":"2024-08-23","current":-9.64162,"twenty":-8.935874,"median":-3.567458,"eighty":-1.495778,"marketCap":725888659},{"date":"2024-08-30","current":-9.226222,"twenty":-8.976913,"median":-3.594054,"eighty":-1.495778,"marketCap":694614544},{"date":"2024-09-06","current":-9.92584,"twenty":-9.085876,"median":-3.621282,"eighty":-1.495778,"marketCap":747286737},{"date":"2024-09-13","current":-9.269948,"twenty":-9.204358,"median":-3.662907,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-09-20","current":-10.144471,"twenty":-9.278737,"median":-3.69958,"eighty":-1.495778,"marketCap":763746797},{"date":"2024-09-27","current":-9.269948,"twenty":-9.335537,"median":-3.746155,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-10-04","current":-8.329835,"twenty":-9.335537,"median":-3.778343,"eighty":-1.505113,"marketCap":627128297},{"date":"2024-10-11","current":-7.87071,"twenty":-9.335537,"median":-3.801653,"eighty":-1.528294,"marketCap":592562170},{"date":"2024-10-18","current":-7.980026,"twenty":-9.335537,"median":-3.834375,"eighty":-1.549946,"marketCap":600792200},{"date":"2024-10-25","current":-7.30227,"twenty":-9.335537,"median":-3.860545,"eighty":-1.556351,"marketCap":549766014},{"date":"2024-10-31","current":-7.958163,"twenty":-9.335537,"median":-3.893503,"eighty":-1.562755,"marketCap":599146194},{"date":"2024-11-08","current":-8.78896,"twenty":-9.353709,"median":-3.91265,"eighty":-1.576715,"marketCap":661694424},{"date":"2024-11-15","current":-6.601047,"twenty":-9.353709,"median":-3.968149,"eighty":-1.588088,"marketCap":547464431},{"date":"2024-11-22","current":-6.704512,"twenty":-9.353709,"median":-4.002514,"eighty":-1.599903,"marketCap":556045378},{"date":"2024-11-29","current":-6.952827,"twenty":-9.353709,"median":-4.031518,"eighty":-1.612485,"marketCap":576639651},{"date":"2024-12-06","current":-7.449457,"twenty":-9.353709,"median":-4.06865,"eighty":-1.643185,"marketCap":617828198},{"date":"2024-12-13","current":-6.932134,"twenty":-9.353709,"median":-4.119828,"eighty":-1.655744,"marketCap":574923462},{"date":"2024-12-20","current":-8.157595,"twenty":-9.353709,"median":-4.147533,"eighty":-1.664831,"marketCap":676558329},{"date":"2024-12-27","current":-8.283874,"twenty":-9.353709,"median":-4.176536,"eighty":-1.687705,"marketCap":687031368},{"date":"2025-01-03","current":-7.753504,"twenty":-9.353709,"median":-4.193651,"eighty":-1.695455,"marketCap":643044603},{"date":"2025-01-10","current":-7.677737,"twenty":-9.371881,"median":-4.217893,"eighty":-1.693654,"marketCap":636760780},{"date":"2025-01-17","current":-7.349413,"twenty":-9.371881,"median":-4.24322,"eighty":-1.693654,"marketCap":609530878},{"date":"2025-01-24","current":-7.273645,"twenty":-9.371881,"median":-4.263547,"eighty":-1.693654,"marketCap":603247055},{"date":"2025-01-31","current":-7.0716,"twenty":-9.371881,"median":-4.295751,"eighty":-1.693654,"marketCap":586490192},{"date":"2025-02-07","current":-7.172623,"twenty":-9.371881,"median":-4.324072,"eighty":-1.708924,"marketCap":594868623},{"date":"2025-02-14","current":-7.147367,"twenty":-9.371881,"median":-4.350344,"eighty":-1.740807,"marketCap":592774015},{"date":"2025-02-21","current":-6.793787,"twenty":-9.371881,"median":-4.368299,"eighty":-1.740807,"marketCap":563449506},{"date":"2025-02-28","current":-6.212905,"twenty":-9.371881,"median":-4.377594,"eighty":-1.761302,"marketCap":515273526},{"date":"2025-03-07","current":-6.566485,"twenty":-9.390054,"median":-4.397509,"eighty":-1.766426,"marketCap":544598035},{"date":"2025-03-14","current":-6.970577,"twenty":-9.390054,"median":-4.426631,"eighty":-1.849687,"marketCap":578111761},{"date":"2025-03-21","current":-7.223134,"twenty":-9.390054,"median":-4.455754,"eighty":-2.630922,"marketCap":599057839},{"date":"2025-03-28","current":-6.073163,"twenty":-9.390054,"median":-4.529252,"eighty":-2.706091,"marketCap":582300976},{"date":"2025-04-04","current":-6.365989,"twenty":-9.390054,"median":-4.555508,"eighty":-2.731148,"marketCap":610377439},{"date":"2025-04-11","current":-5.795246,"twenty":-9.371881,"median":-4.597373,"eighty":-2.756204,"marketCap":555653944},{"date":"2025-04-17","current":-6.431845,"twenty":-9.371881,"median":-4.606018,"eighty":-2.78126,"marketCap":616691688},{"date":"2025-04-25","current":-7.178202,"twenty":-9.390054,"median":-4.631607,"eighty":-2.806317,"marketCap":688253181},{"date":"2025-05-02","current":-7.15625,"twenty":-9.390054,"median":-4.638411,"eighty":-2.831373,"marketCap":686148431},{"date":"2025-05-09","current":-7.072289,"twenty":-9.390054,"median":-4.657196,"eighty":-2.85643,"marketCap":678098122},{"date":"2025-05-16","current":-6.413042,"twenty":-9.390054,"median":-4.661881,"eighty":-2.873318,"marketCap":655246189},{"date":"2025-05-23","current":-6.041869,"twenty":-9.390054,"median":-4.688734,"eighty":-2.888127,"marketCap":617321972},{"date":"2025-05-30","current":-4.61904,"twenty":-9.390054,"median":-4.689631,"eighty":-2.910465,"marketCap":471945808},{"date":"2025-06-06","current":-4.90773,"twenty":-9.390054,"median":-4.717857,"eighty":-2.931599,"marketCap":501442421},{"date":"2025-06-13","current":-4.660282,"twenty":-9.390054,"median":-4.745129,"eighty":-2.956655,"marketCap":476159610},{"date":"2025-06-20","current":-4.268488,"twenty":-9.408226,"median":-4.745129,"eighty":-2.972398,"marketCap":436128492},{"date":"2025-06-25","current":-4.701523,"twenty":-9.408226,"median":-4.745129,"eighty":-2.981712,"marketCap":480373412}],"updateTime":1750941673591}}}